Resources
Related Categories
|
Also Recommended
|
|
|
The Elements of Effective Advocacy in the Federal Circuit
Mark Simon Davies
£60.00
|
|
|
|
|
Joel Davidow
£110.00
|
|
|
|
|
World Protection and Exploitation
Duncan Bucknell
£295.00
|
|
|
|
|
Drafting Agreements in the Biotechnology and Pharmaceutical Industries
Edited by Mark Anderson Caroline de Mareuil-Villette, Magali Touroude, Christine Kanz, Heike Wachenhausen, Carla Schoonderbeek, Pablo Olivera, Dulce Miranda Naranjo, and Eric Runesson
c.1200 pages
|
246x171mm
978-0-19-953963-5
|
Looseleaf
|
02 April 2009
Mainwork
Price:
£395.00
(Includes first-year updating)
Subsequent Annual Service: £195.00
This product is regularly updated with new releases (approx 1 releases per year). Subscribers to the annual service will receive new releases as they become available.
Publication Date of Next Release:
March 2010
|
|
|
|
|
- Offers precedent agreements and legal commentary in relation to the main types of commercial transaction encountered in the life-cycle of a product in in the biotechnology and pharmaceutical industries
- Supported by an online resource providing plain versions of all the precedents which can be downloaded and edited by the user
- Provides detailed commentary to each precedent on legal, commercial and practice issues
- Highlights the important differences between English law and other key EU jurisdictions comprising Germany, France, the Netherlands, Spain and Sweden. The first updating release will also highlight differences between English and US law
- Incorporates commentary from specialist lawyers within key EU jurisductions and the US
This looseleaf provides precedent agreements and legal commentary in relation to the main types of commercial transaction encountered in the life-cycle of a product in the biotechnology and pharmaceutical industries. Each agreement is accompanied by detailed commentary on legal, commercial and practice issues. In addition the commentary will highlight important differences between English law and other key EU jurisdictions comprising Germany, France, the Netherlands, Spain and Sweden with specific commentary being provided by specialist lawyers within these countries. Further commentary on the US specific issues will be provided in
the first updating release.
The third part of the looseleaf incorporates a separate summary and discussion of legal issues that are common to different types of agreement, relevant statutory and legal materials and website links to other relevant materials.
The looseleaf is published with an accompanying online resource providing plain versions of all the precedents which can be downloaded and edited to enable the user to create and amend precedents based on those provided by the work..
Annual updating releases will provide both new precedent material and commentary covering important developments within the field.Readership: Lawyers and
commercial managers who are involved in drafting and negotiating agreements in the biotechnology and pharmaceutical industries, including university technology transfer managers, IP licensing practitioners and product development managers in biotechnology or pharmaceutical companies.
|
|
|
The update to be published in March 2010 will add US commentary on the agreements.
|
|
|
Edited by Mark Anderson, Anderson & Company Caroline de Mareuil-Villette, Cabinet Plasseraud, Magali Touroude, Cabinet Plasseraud, Christine Kanz, Reimann Osterrieth Köhler Haft, Heike Wachenhausen, Anwaltskanzlei Sträter, Carla Schoonderbeek, NautaDutilh, Pablo Olivera, Garrigues, Dulce Miranda Naranjo, Garrigues, and Eric Runesson, Sandart & Partners Advokatbyrå
|
|
|
"Drafting Agreements in the Biotechnology and Pharmaceutical Industries is a "must-have" reference for life science lawyers and Business Development executives. The short but insightful commentary to each sample form agreement provides the essential context, while the footnote annotations to the clauses of each form drill down for a more focused commentary. Although initially prepared for use in the European market, American readers will benefit greatly from this important compilation." - Brian D. Beglin, Bingham McCutchen LLP, USA
|
|
|
Part A: Introduction
1: Introduction to agreements in the Bio/Pharma sector
Part B: Annotated precedents
2: Preliminary agreements
3: Collaborative research and development agreements
4: Services agreements
5: Clinical trials agreements
6: Product manufacturing and supply agreements
7: Distribution and marketing agreements
8: Licence agreements
9: Assignments
Part C: General commentary
10: Regulations affecting the research and development of pharmaceutical products
11: Intellectual property law in Europe
12: Competition law issues
13: Contract law and practice
14: Tax and currency issues
Part D: Materials
16: Selected EC competition law materials
17: Web-site links to other selected materials
|
|
|
Ordering Looseleaf and Bound Volume products from Oxford University Press This product is available to order by contacting our Law Customer Services team. They can also be contacted for more information on this or any other law subscription product, including information on how to subscribe, frequency of updating, postage charges and delivery times. Law Customer Services team: Telephone: +44 (0) 1536 454545 Email: lawsubscriptions.uk@oup.com Fax: +44 (0) 1536 741894
|
|
|
|
Recently Viewed
|
|
|
From Sumer to Spreadsheets
Martin Campbell-Kelly, Mary Croarken...
£68.00
|
|
|
|
|
Windows Individual Academic User Version 1.0
Geoffrey Marston
£430.00
+ VAT
|
|
|
|
|
Anthony Powers
Vocal score
£2.15
|
|
|
|
The specification in this catalogue, including without limitation price, format, extent, number of illustrations, and month of publication, was as accurate as possible at the time the catalogue was compiled. Occasionally, due to the nature of some contractual restrictions, we are unable to ship a specific product to a particular territory. Jacket images are provisional and liable to change before publication.
|
|